• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adiposity factors are not related to the presence of colorectal adenomas.肥胖因素与结肠直肠腺瘤的存在无关。
Clin Exp Gastroenterol. 2011;4:257-61. doi: 10.2147/CEG.S25594. Epub 2011 Nov 15.
2
Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.内脏脂肪堆积及血浆脂联素与结肠直肠腺瘤的关联:胰岛素抵抗参与的证据
Clin Cancer Res. 2005 May 15;11(10):3642-6. doi: 10.1158/1078-0432.CCR-04-1868.
3
The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.血清脂联素与抵抗素水平、胰岛素抵抗及结直肠腺瘤之间的关系。
Turk J Gastroenterol. 2015 Jan;26(1):20-4. doi: 10.5152/tjg.2015.3626.
4
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study.息肉切除术后结直肠癌发病和死亡风险:一项瑞典的记录链接研究。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):537-547. doi: 10.1016/S2468-1253(20)30009-1. Epub 2020 Mar 17.
5
Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.内脏肥胖和胰岛素抵抗作为结直肠腺瘤的危险因素:一项横断面、病例对照研究。
Am J Gastroenterol. 2010 Jan;105(1):178-87. doi: 10.1038/ajg.2009.541. Epub 2009 Sep 15.
6
Clinical significance of small polyps found during screening with flexible sigmoidoscopy.乙状结肠镜筛查中发现的小息肉的临床意义。
Gastrointest Endosc Clin N Am. 2002 Jan;12(1):41-51. doi: 10.1016/s1052-5157(03)00056-4.
7
[Distribution characteristics and risk factors of colorectal adenomas].[结直肠腺瘤的分布特征及危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jun 25;21(6):678-684.
8
Association of colorectal adenoma with components of metabolic syndrome.结直肠腺瘤与代谢综合征组分的关系。
Cancer Causes Control. 2012 May;23(5):727-35. doi: 10.1007/s10552-012-9942-9. Epub 2012 Mar 27.
9
IGF-I levels and visceral fat accumulation in colonic neoplasia.IGF-I 水平与结直肠肿瘤患者内脏脂肪堆积。
Clin Res Hepatol Gastroenterol. 2014 Feb;38(1):99-105. doi: 10.1016/j.clinre.2013.06.004. Epub 2013 Aug 14.
10
Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas.结直肠腺瘤患者高密度脂蛋白胆固醇水平降低,低密度脂蛋白胆固醇水平升高。
Ann Intern Med. 1993 Apr 1;118(7):481-7. doi: 10.7326/0003-4819-118-7-199304010-00001.

引用本文的文献

1
The role of BMI, serum lipid profile molecules and their derivative indexes in colorectal polyps.体重指数、血脂谱分子及其衍生指标在结直肠息肉中的作用。
Adv Lab Med. 2024 Apr 26;5(3):276-282. doi: 10.1515/almed-2023-0170. eCollection 2024 Sep.
2
[Not Available].[不可用]。
Adv Lab Med. 2024 May 20;5(3):283-290. doi: 10.1515/almed-2024-0060. eCollection 2024 Sep.
3
Systemic adiponectin levels in colorectal cancer and adenoma: a systematic review and meta-analysis.结直肠癌和腺瘤患者血清脂联素水平:系统评价和荟萃分析。
Int J Obes (Lond). 2023 Oct;47(10):911-921. doi: 10.1038/s41366-023-01358-6. Epub 2023 Aug 25.
4
Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis.循环总脂联素水平低,尤其是其非高分子量部分,是结直肠癌一个有前景的风险因素:一项荟萃分析。
Onco Targets Ther. 2018 May 4;11:2519-2531. doi: 10.2147/OTT.S157255. eCollection 2018.
5
Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.C反应蛋白、白细胞介素-6和肿瘤坏死因子-α的循环水平与结直肠腺瘤风险:一项荟萃分析。
Oncotarget. 2016 Sep 27;7(39):64371-64379. doi: 10.18632/oncotarget.11853.
6
Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas.血浆胰岛素、葡萄糖、胰岛素样生长因子-I、胰岛素样生长因子-II、胰岛素样生长因子结合蛋白-3与结直肠腺瘤复发风险
J Gastroenterol Hepatol Res. 2013 Apr 14;2(4):531-535. doi: 10.6051/j.issn.2224-3992.2013.02.247.
7
Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls.与健康对照组相比,结直肠肿瘤患者和病态肥胖患者的脂肪细胞因子浓度发生了变化。
BMC Cancer. 2012 Nov 23;12:545. doi: 10.1186/1471-2407-12-545.

本文引用的文献

1
Interaction between adiponectin and leptin influences the risk of colorectal adenoma.脂联素与瘦素的相互作用影响结直肠腺瘤的风险。
Cancer Res. 2010 Jul 1;70(13):5430-7. doi: 10.1158/0008-5472.CAN-10-0178. Epub 2010 Jun 1.
2
Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.《息肉预防试验》中血清脂联素、瘦素、C 肽、同型半胱氨酸与结直肠腺瘤复发的关系
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1441-52. doi: 10.1158/1055-9965.EPI-09-1082. Epub 2010 May 25.
3
Insulin resistance and cancer: epidemiological evidence.胰岛素抵抗与癌症:流行病学证据。
Cancer Sci. 2010 May;101(5):1073-9. doi: 10.1111/j.1349-7006.2010.01521.x. Epub 2010 Feb 3.
4
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.脂肪细胞因子作为结直肠肿瘤新的有前途的标志物:脂联素用于结直肠腺瘤,抵抗素和内脂素用于结直肠癌。
Cancer Sci. 2010 May;101(5):1286-91. doi: 10.1111/j.1349-7006.2010.01518.x. Epub 2010 Jan 31.
5
Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer.血浆脂联素水平降低与结直肠癌风险增加相关。
World J Gastroenterol. 2010 Mar 14;16(10):1252-7. doi: 10.3748/wjg.v16.i10.1252.
6
Association between adiponectin, resistin, insulin resistance, and colorectal tumors.脂联素、抵抗素、胰岛素抵抗与结直肠肿瘤的关系。
Int J Colorectal Dis. 2010 Feb;25(2):205-12. doi: 10.1007/s00384-009-0828-6. Epub 2009 Nov 4.
7
Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.内脏肥胖和胰岛素抵抗作为结直肠腺瘤的危险因素:一项横断面、病例对照研究。
Am J Gastroenterol. 2010 Jan;105(1):178-87. doi: 10.1038/ajg.2009.541. Epub 2009 Sep 15.
8
Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.结直肠腺瘤和癌(CC)患者的血清瘦素、脂联素和抵抗素浓度。
Int J Colorectal Dis. 2009 Mar;24(3):275-81. doi: 10.1007/s00384-008-0605-y. Epub 2008 Nov 1.
9
Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia.内脏脂肪堆积及脂联素水平与结直肠肿瘤的关联
Dig Dis Sci. 2009 Apr;54(4):862-8. doi: 10.1007/s10620-008-0440-6. Epub 2008 Aug 21.
10
Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition.脂联素在高脂饮食条件下抑制结直肠癌发生。
Gut. 2008 Nov;57(11):1531-8. doi: 10.1136/gut.2008.159293. Epub 2008 Aug 1.

肥胖因素与结肠直肠腺瘤的存在无关。

Adiposity factors are not related to the presence of colorectal adenomas.

作者信息

Chronis Aris, Thomopoulos Konstantinos, Sapountzis Apostolos, Triantos Christos, Kalafateli Maria, Kalofonos Charalampos, Nikolopoulou Vassiliki

机构信息

Department of Internal Medicine, Division of Gastroenterology, University Hospital, Patras, Greece.

出版信息

Clin Exp Gastroenterol. 2011;4:257-61. doi: 10.2147/CEG.S25594. Epub 2011 Nov 15.

DOI:10.2147/CEG.S25594
PMID:22162929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3234123/
Abstract

PURPOSE

Adiposity has been thought to be related to colorectal carcinogenesis. The aim of this study was to explore any association between obesity factors and the presence of colorectal adenoma, a potential precancerous lesion.

PATIENTS AND METHODS

Two hundred and six consecutive patients undergoing colonoscopy without colorectal cancer were enrolled in the study. Anthropometric measures and other adiposity-related laboratory variables including insulin resistance and serum adiponectin levels were recorded and correlated with the presence of adenoma.

RESULTS

Colorectal adenoma was detected in 68/206 patients (33%), tubular adenoma(s) in 38 patients, and tubulovillous or villous in 30 patients. Twenty-one patients (10.2%) had at least one proximal polyp. The size of the largest adenoma was ≤10 mm in 40 patients and >10 mm in 28 patients. No statistically significant difference was observed in body mass index, waist circumference, fasting plasma glucose concentration, insulin, homeostatic metabolic assessment, cholesterol, low-density lipoproteins, high-density lipoprotein, or triglycerides between patients with and without adenoma. In addition, there was no difference in plasma adiponectin between patients with adenoma (11.1 ± 6 μg/mL) and controls (10.2 ± 7.8 μg/mL). Furthermore, no significant difference in any parameter was found between patients with advanced adenoma and no advanced adenoma, nor between patients with proximal or distal tumors.

CONCLUSION

This study found that the presence of colorectal adenoma is not correlated with any adiposity factor. Moreover, obesity does not appear to be associated with the site or the presence of more advanced lesions.

摘要

目的

肥胖一直被认为与结直肠癌的发生有关。本研究旨在探讨肥胖因素与结直肠腺瘤(一种潜在的癌前病变)的存在之间的任何关联。

患者与方法

连续纳入206例接受结肠镜检查且无结直肠癌的患者。记录人体测量指标和其他与肥胖相关的实验室变量,包括胰岛素抵抗和血清脂联素水平,并将其与腺瘤的存在情况进行关联分析。

结果

206例患者中有68例(33%)检测到结直肠腺瘤,38例为管状腺瘤,30例为管状绒毛状或绒毛状腺瘤。21例患者(10.2%)至少有一个近端息肉。最大腺瘤的大小≤10 mm的有40例,>10 mm的有28例。腺瘤患者与无腺瘤患者在体重指数、腰围、空腹血糖浓度、胰岛素、稳态代谢评估、胆固醇、低密度脂蛋白、高密度脂蛋白或甘油三酯方面未观察到统计学上的显著差异。此外,腺瘤患者(11.1±6 μg/mL)与对照组(10.2±7.8 μg/mL)的血浆脂联素水平也无差异。此外,进展期腺瘤患者与非进展期腺瘤患者之间,以及近端或远端肿瘤患者之间,在任何参数上均未发现显著差异。

结论

本研究发现结直肠腺瘤的存在与任何肥胖因素均无相关性。此外,肥胖似乎与病变部位或更晚期病变的存在无关。